Trusted Across The Region
We are proud to have earned the trust of leading health authorities, pharmaceutical manufacturers, and healthcare organizations across the Middle East region
Founded in 1920, the Iraqi Ministry of Health is the principal government health authority overseeing public health policy, regulation, and healthcare services across Iraq.
Government Health Authority
Strategic Alliances
We collaborate with specialist organizations who share our commitment to excellence in healthcare and pharmaceutical services
Inotek Technologies is a specialist consulting firm focused on regulatory-driven design and engineering for pharmaceutical facilities.
Visit Website
Who We Serve
We partner with diverse organizations across the healthcare and pharmaceutical ecosystem
Success Stories
"The training covered all principles related to pharmacovigilance in a brief and focused way that allows the participant to build an integrated image of the topic. The sessions related to self-assessment and knowing the surrounding work environment were very useful and rich in information enabling the participant to benefit from supportive superiors to solve problems faced at work."
"Incredible professionalism and a genuine commitment to client success. We've experienced remarkable growth and efficiency improvements since partnering with them. The team's regional expertise and strong relationships with key stakeholders made our market entry seamless. Couldn't be more satisfied!"
"Working with 7D Consultancy has been transformative for our organization. Their execution-focused approach and deep understanding of regulatory frameworks helped us establish a robust pharmacovigilance system that exceeded all inspection requirements. The team's ability to deliver clear KPIs and measurable results, combined with their fast turnaround on critical deliverables, sets them apart. A true strategic partner in every sense."
Competitive Advantage
Deep understanding of GCC, Iraq, and emerging-market regulatory frameworks and dynamics with proven track record of success.
Direct access to regulators, payers, key opinion leaders, and healthcare decision-makers across all target markets.
Real-world evidence, advanced analytics, and health-economics research capabilities for informed decision-making.
Biosimilars, biologics, plasma-derived therapies, specialty care, and rare diseases expertise across therapeutic areas.
2–3 week diagnostic sprints with flexible, agile engagement models that adapt to your timeline and priorities.
End-to-end delivery with clear KPIs, team building, and results-driven partnerships that ensure success.
Let's unlock growth and access in complex markets together. Contact us to discuss how we can support your organization's goals.